InBioGen Co Ltd Capital Reinvestment Ratio

Latest as of December 2024: 0.04x

InBioGen Co Ltd capital reinvestment ratio. InBioGen Co Ltd (101140) has a Capital Reinvestment Ratio of 0.04x as of December 2024, meaning it reinvests 0% of its operating cash flow (₩1.36 Billion) in capital expenditures (₩60.00 Million). Check 101140 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.04x

Capex / Operating Cash Flow

Operating Cash Flow

₩1.36 Billion

KRW

Capital Expenditures

₩60.00 Million

KRW

Data as of

Dec 2024

Most recent filing

InBioGen Co Ltd Capital Reinvestment Ratio by Year (None–None)

InBioGen Co Ltd capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see 101140 cash flow metrics.

Year	Reinvestment Ratio	Operating CF (KRW)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow